Circulating Palmitoleic Acid is an Independent Determinant of Insulin Sensitivity, Beta Cell Function and Glucose Tolerance in Non-diabetic Individuals: a Longitudinal Analysis

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2019 Nov 3

PMID 31676981

Citations 27

Authors

Domenico Trico

Alessandro Mengozzi

Lorenzo Nesti

Mensud Hatunic

Rafael Gabriel Sanchez

Thomas Konrad

Katarina Lalic

Nebojsa M Lalic

Andrea Mari

Andrea Natali

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: Experimental studies suggest that the fatty acid palmitoleate may act as an adipocyte-derived lipid hormone (or 'lipokine') to regulate systemic metabolism. We investigated the relationship of circulating palmitoleate with insulin sensitivity, beta cell function and glucose tolerance in humans.

Methods: Plasma NEFA concentration and composition were determined in non-diabetic individuals from the Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) study cohort at baseline (n = 1234) and after a 3 year follow-up (n = 924). Glucose tolerance, insulin secretion and beta cell function were assessed during an OGTT. Whole-body insulin sensitivity was measured by a hyperinsulinaemic-euglycaemic clamp (M/I) and OGTT (oral glucose insulin sensitivity index [OGIS]). The liver insulin resistance index was calculated using clinical and biochemical data. Body composition including fat mass was determined by bioelectrical impedance.

Results: Circulating palmitoleate was proportional to fat mass (r = 0.21, p < 0.0001) and total NEFA levels (r = 0.19, p < 0.0001). It correlated with whole-body insulin sensitivity (M/I: standardised regression coefficient [std. β] = 0.16, p < 0.0001), liver insulin resistance (std. β = -0.14, p < 0.0001), beta cell function (potentiation: std. β = 0.08, p = 0.045) and glucose tolerance (2 h glucose: std. β = -0.24, p < 0.0001) after adjustment for age, sex, BMI, adiposity and other NEFA. High palmitoleate concentrations prevented the decrease in insulin sensitivity associated with excess palmitate (p = 0.0001). In a longitudinal analysis, a positive independent relationship was observed between changes in palmitoleate and insulin sensitivity over time (std. β = 0.07, p = 0.04).

Conclusions/interpretation: We demonstrated that plasma palmitoleate is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals. These results support the role of palmitoleate as a beneficial lipokine released by adipose tissue to prevent the negative effects of adiposity and excess NEFA on systemic glucose metabolism.

Citing Articles

Rare variants in the melanocortin 4 receptor gene (MC4R) are associated with abdominal fat and insulin resistance in youth with obesity.

Galuppo B, Mannam P, Bonet J, Pierpont B, Trico D, Haskell-Luevano C Int J Obes (Lond). 2024; .

PMID: 39738493 DOI: 10.1038/s41366-024-01706-0.

The role of adipose tissue dysfunction in hepatic insulin resistance and T2D.

Sancar G, Birkenfeld A J Endocrinol. 2024; 262(3).

PMID: 38967989 PMC: 11378142. DOI: 10.1530/JOE-24-0115.

Palmitate and group B synergistically and differentially induce IL-1β from human gestational membranes.

Gaddy J, Moore R, Lochner J, Rogers L, Noble K, Giri A Front Immunol. 2024; 15:1409378.

PMID: 38855112 PMC: 11158625. DOI: 10.3389/fimmu.2024.1409378.

Hypoglycemic Activity of Rice Resistant-Starch Metabolites: A Mechanistic Network Pharmacology and In Vitro Approach.

Ren J, Dai J, Chen Y, Wang Z, Sha R, Mao J Metabolites. 2024; 14(4).

PMID: 38668351 PMC: 11052319. DOI: 10.3390/metabo14040224.

Protocol for a randomized placebo-controlled clinical trial using pure palmitoleic acid to ameliorate insulin resistance and lipogenesis in overweight and obese subjects with prediabetes.

Cetin E, Pedersen B, Porter L, Adler G, Burak M Front Endocrinol (Lausanne). 2024; 14:1306528.

PMID: 38313838 PMC: 10835623. DOI: 10.3389/fendo.2023.1306528.

References

Maeda K, Cao H, Kono K, Gorgun C, Furuhashi M, Uysal K . Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 2005; 1(2):107-19. DOI: 10.1016/j.cmet.2004.12.008. View

Knutsen S, Fraser G, Beeson W, Lindsted K, Shavlik D . Comparison of adipose tissue fatty acids with dietary fatty acids as measured by 24-hour recall and food frequency questionnaire in Black and White Adventists: the Adventist Health Study. Ann Epidemiol. 2003; 13(2):119-27. DOI: 10.1016/s1047-2797(02)00260-0. View

Maedler K, Oberholzer J, Bucher P, Spinas G, Donath M . Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003; 52(3):726-33. DOI: 10.2337/diabetes.52.3.726. View

Griel A, Cao Y, Bagshaw D, Cifelli A, Holub B, Kris-Etherton P . A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J Nutr. 2008; 138(4):761-7. DOI: 10.1093/jn/138.4.761. View

Cao H, Gerhold K, Mayers J, Wiest M, Watkins S, Hotamisligil G . Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008; 134(6):933-44. PMC: 2728618. DOI: 10.1016/j.cell.2008.07.048. View

Hiraoka-Yamamoto J, Ikeda K, Negishi H, Mori M, Hirose A, Sawada S . Serum lipid effects of a monounsaturated (palmitoleic) fatty acid-rich diet based on macadamia nuts in healthy, young Japanese women. Clin Exp Pharmacol Physiol. 2005; 31 Suppl 2:S37-8. DOI: 10.1111/j.1440-1681.2004.04121.x. View

Mozaffarian D, Cao H, King I, Lemaitre R, Song X, Siscovick D . Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr. 2010; 92(6):1350-8. PMC: 2980960. DOI: 10.3945/ajcn.110.003970. View

Palomer X, Pizarro-Delgado J, Barroso E, Vazquez-Carrera M . Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus. Trends Endocrinol Metab. 2018; 29(3):178-190. DOI: 10.1016/j.tem.2017.11.009. View

Nestel P, Clifton P, Noakes M . Effects of increasing dietary palmitoleic acid compared with palmitic and oleic acids on plasma lipids of hypercholesterolemic men. J Lipid Res. 1994; 35(4):656-62. View

10.

Hodson L, Fielding B . Stearoyl-CoA desaturase: rogue or innocent bystander?. Prog Lipid Res. 2012; 52(1):15-42. DOI: 10.1016/j.plipres.2012.08.002. View

11.

Opie L, Walfish P . Plasma free fatty acid concentrations in obesity. N Engl J Med. 1963; 268:757-60. DOI: 10.1056/NEJM196304042681404. View

12.

Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T . Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med. 2007; 13(10):1193-202. DOI: 10.1038/nm1662. View

13.

Carta G, Murru E, Banni S, Manca C . Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. Front Physiol. 2017; 8:902. PMC: 5682332. DOI: 10.3389/fphys.2017.00902. View

14.

Boden G, Shulman G . Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 2002; 32 Suppl 3:14-23. DOI: 10.1046/j.1365-2362.32.s3.3.x. View

15.

Venturi E, Pinnola S, Morizzo C, Boldrini B, Rossi M, Trifiro S . Clinical Phenotype and Microvascular Dynamics of Subjects with Endothelial Dysfunction as Assessed by Peripheral Tonometry. Microcirculation. 2016; 23(3):230-9. DOI: 10.1111/micc.12268. View

16.

Yang Z, Miyahara H, Hatanaka A . Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes. Lipids Health Dis. 2011; 10:120. PMC: 3155149. DOI: 10.1186/1476-511X-10-120. View

17.

Hodson L, Skeaff C, Fielding B . Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008; 47(5):348-80. DOI: 10.1016/j.plipres.2008.03.003. View

18.

Gravena C, Mathias P, Ashcroft S . Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. J Endocrinol. 2002; 173(1):73-80. DOI: 10.1677/joe.0.1730073. View

19.

Boden G . Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care. 2002; 5(5):545-9. DOI: 10.1097/00075197-200209000-00014. View

20.

Garg M, Blake R, Wills R . Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J Nutr. 2003; 133(4):1060-3. DOI: 10.1093/jn/133.4.1060. View